Company and Stock Identity

How Navina Connects to the Public Market

Company structure
Private company
Market access
No current public listing was verified.
Research focus
Compare the chart evidence behind each suggestion with clinician decisions and care-gap follow-through. Coding changes alone do not establish better care.

Navina is privately held. Company sources are the starting point for ownership and business updates.

Open the public company market data feed for the full directory, ownership relationships, stock identifiers, and dated snapshots.

First-Hand Company News

Latest Developments

No dated update is in the editorial file yet. Use the verified company sources below and check the profile verification date before relying on an older announcement.

See company developments across the healthcare AI market.

Careers and Qualifications

What to Know Before Applying

Work areas: Clinical AI and engineering roles sit beside customer implementation. Commercial teams work with provider groups and health plans.

Qualification signal: Health-data and clinical workflow experience can support implementation work. Risk-adjustment roles need knowledge of diagnosis documentation and its rules.

Check current roles at Navina. A careers page is the source of record for openings. This profile does not claim a role is open unless the company lists it now.

Related Healthcare AI Roles

Training to Compare

Buyer Snapshot

Best-fit buyer
CMIO, quality and safety, nursing leadership, clinical informatics, data science, and service-line owners
Primary use case
Surface patient risk, deterioration signals, or clinical recommendations for review
Typical deployment
Usually embedded in the EHR or connected to streaming clinical data with alerts delivered inside existing workflows

Evidence questions

  • What population, prevalence, and care setting were used for validation?
  • Has the tool been tested prospectively against the current workflow?
  • What clinical and operational outcomes improved beyond model accuracy?

Regulatory and workflow questions

  • Does the intended use place the software under FDA device oversight?
  • What does the clinician see before acting on the score or alert?
  • Who owns performance review, adverse event review, and suspension decisions?

Data and contract questions

  • Which inputs are required and how are missing or delayed data handled?
  • How are model updates, feature changes, and drift disclosed?
  • Can local performance be measured by patient subgroup and clinical unit?

Evidence and Regulation

FDA Clearances on Record

No clearance is linked in this directory. That is not automatically a mark against the company. Some products support the people doing the work instead of reading a patient image or signal themselves.

What the Published Research Says About This Work

Independent studies on the work itself help separate category evidence from one company's claims.

First-Hand Sources